Subcutaneous Trastuzumab with Pertuzumab and Docetaxel in HER2-Positive Metastatic Breast Cancer: Final Analysis of MetaPHER, A Phase 3b Single-Arm Safety Study

Sherko Kümmel, Miguel Martín, Jacinta Abraham et al.|Research Square|2020

Cited by 1